Autoimmune retinopathy

Area of Science:

• Ophthalmology
• Immunology
• Autoimmune Diseases

Background:

• Autoimmune retinopathy (AIR) is an immune-mediated condition causing progressive vision loss.
• Characterized by anti-retinal antibodies, abnormal electroretinography, and visual field defects.
• Pathophysiology involves autoantibodies targeting retinal tissue, with variable findings and potential links to self-tolerance issues.

Purpose of the Study:

• To review recent advances in understanding the pathophysiology of autoimmune retinopathy.
• To highlight current clinical manifestations and evolving management strategies for AIR.
• To discuss the role of emerging diagnostic and therapeutic approaches.

Main Methods:

• Literature review focusing on pathophysiology, clinical features, and treatment of autoimmune retinopathy.
• Analysis of recent research on anti-retinal antibodies and immunomodulatory therapies.
• Evaluation of newer imaging modalities for diagnosis and monitoring.

Main Results:

• AIR pathophysiology is likely antibody-mediated, though autoantibodies can be found in healthy individuals.
• Standardized antibody testing methods are lacking, complicating diagnosis and interpretation.
• Immunomodulatory therapies, including targeted B-cell therapy, show promise.
• Advanced imaging like OCT and fundus autofluorescence aid in diagnosis and monitoring.

Conclusions:

• Autoimmune retinopathy is a rare, vision-threatening disease with an incompletely defined pathogenesis.
• Diagnostic challenges persist due to a lack of standardized criteria.
• Further basic science research and controlled clinical trials are essential for refining treatment paradigms.